欧普康视(300595)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300595 欧普康视

已收盘 04-30 15:00:00

{"stockData":{"symbol":"300595","market":"SZ","secType":"STK","nameCN":"欧普康视","latestPrice":14.42,"timestamp":1777532628000,"preClose":14.29,"halted":0,"volume":18406762,"delay":0,"changeRate":0.0091,"floatShares":668000000,"shares":894999999,"eps":0.5199,"marketStatus":"已收盘","change":0.13,"latestTime":"04-30 15:00:00","open":14.71,"high":15.18,"low":14.4,"amount":271000000,"amplitude":0.0546,"askPrice":14.42,"askSize":258,"bidPrice":14.41,"bidSize":1500,"shortable":0,"etf":0,"ttmEps":0.5199,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1778031000000},"marketStatusCode":5,"adr":0,"adjPreClose":14.29,"symbolType":"stock","openAndCloseTimeList":[[1777512600000,1777519800000],[1777525200000,1777532400000]],"highLimit":15.72,"lowLimit":12.86,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":895289123,"isCdr":false,"pbRate":2.53,"roa":"--","peRate":27.736103,"roe":"2.93%","epsLYR":0.537,"committee":0.254805,"marketValue":12910000000,"turnoverRate":0.0275,"status":0,"floatMarketCap":9640000000},"requestUrl":"/m/hq/s/300595","defaultTab":"news","newsList":[{"id":"2631552344","title":"欧普康视：阿托品项目仍在临床试验中","url":"https://stock-news.laohu8.com/highlight/detail?id=2631552344","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631552344?lang=zh_cn&edition=full","pubTime":"2026-04-29 11:38","pubTimestamp":1777433880,"startTime":"0","endTime":"0","summary":"证券之星消息，欧普康视(300595)04月28日在投资者关系平台上答复投资者关心的问题。投资者提问：公司的阿托品滴眼液临床试验有什么新进展吗？欧普康视回复：您好，阿托品项目仍在临床试验中，其属于药品，公司会按照规则披露进展。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900037792.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300595","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631355258","title":"欧普康视：截止到2026年4月20日，公司股东总人数为61,017户","url":"https://stock-news.laohu8.com/highlight/detail?id=2631355258","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631355258?lang=zh_cn&edition=full","pubTime":"2026-04-29 11:37","pubTimestamp":1777433869,"startTime":"0","endTime":"0","summary":"证券之星消息，欧普康视(300595)04月28日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵公司到4月27日为止股东人数是多少？欧普康视回复：您好，截止到2026年4月20日，公司股东总人数为61,017户。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900037776.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300595","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630356286","title":"欧普康视：公司未发布过上述方案，消息不实","url":"https://stock-news.laohu8.com/highlight/detail?id=2630356286","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630356286?lang=zh_cn&edition=full","pubTime":"2026-04-27 11:33","pubTimestamp":1777260818,"startTime":"0","endTime":"0","summary":"证券之星消息，欧普康视(300595)04月27日在投资者关系平台上答复投资者关心的问题。投资者提问：公司2025年10月发布的15亿～30亿元的回购方案实施了吗？还是又要延期？欧普康视回复：您好，公司未发布过上述方案，消息不实。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700017539.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629840011","title":"欧普康视（300595）2026年一季报简析：净利润同比下降8.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629840011","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629840011?lang=zh_cn&edition=full","pubTime":"2026-04-24 22:38","pubTimestamp":1777041531,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期欧普康视发布2026年一季报。根据财报显示，欧普康视净利润同比下降8.79%。截至本报告期末，公司营业总收入4.59亿元，同比下降3.92%，归母净利润1.46亿元，同比下降8.79%。本次财报公布的各项数据指标表现不尽如人意。去年的净利率为29.23%，算上全部成本后，公司产品或服务的附加值高。从历史年报数据统计来看，公司上市以来中位数ROIC为24.09%，投资回报也很好，其中最惨年份2025年的ROIC为9.76%，投资回报也较好。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400065615.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629088493","title":"欧普康视(300595)4月20日股东户数6.1万户，较上期减少0.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629088493","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629088493?lang=zh_cn&edition=full","pubTime":"2026-04-23 17:37","pubTimestamp":1776937032,"startTime":"0","endTime":"0","summary":"证券之星消息，近日欧普康视披露，截至2026年4月20日公司股东户数为6.1万户，较4月10日减少30.0户，减幅为0.05%。在医疗器械行业个股中，欧普康视股东户数高于行业平均水平，截至4月20日，医疗器械行业平均股东户数为2.2万户。从股价来看，2026年4月10日至2026年4月20日，欧普康视区间跌幅为1.13%，在此期间股东户数减少30.0户，减幅为0.05%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300048593.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300595","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629028775","title":"欧普康视(300595.SZ)发布一季度业绩，归母净利润1.46亿元，下降8.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629028775","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629028775?lang=zh_cn&edition=full","pubTime":"2026-04-22 23:07","pubTimestamp":1776870469,"startTime":"0","endTime":"0","summary":"智通财经APP讯，欧普康视(300595.SZ)发布2026年第一季度报告，该公司营业收入为4.59亿元，同比减少3.92%。归属于上市公司股东的净利润为1.46亿元，同比减少8.79%。归属于上市公司股东的扣除非经常性损益的净利润为1.2亿元，同比减少18.64%。基本每股收益为0.1637元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1432272.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"欧普康视(300595.SZ)发布一季度业绩，归母净利润1.46亿元，下降8.79%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629084339","title":"欧普康视(300595)4月20日股东户数6.1万户，较上期减少0.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629084339","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629084339?lang=zh_cn&edition=full","pubTime":"2026-04-21 17:21","pubTimestamp":1776763268,"startTime":"0","endTime":"0","summary":"证券之星消息，近日欧普康视披露，截至2026年4月20日公司股东户数为6.1万户，较4月10日减少30.0户，减幅为0.05%。在医疗器械行业个股中，欧普康视股东户数高于行业平均水平，截至4月20日，医疗器械行业平均股东户数为2.19万户。从股价来看，2026年4月10日至2026年4月20日，欧普康视区间跌幅为1.13%，在此期间股东户数减少30.0户，减幅为0.05%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042100039301.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628793941","title":"股市必读：欧普康视(300595)股东户数6.1万户，较上期减少0.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628793941","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628793941?lang=zh_cn&edition=full","pubTime":"2026-04-20 02:44","pubTimestamp":1776624248,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘，欧普康视报收于13.99元，下跌1.55%，换手率1.65%，成交量11.04万手，成交额1.54亿元。来自股本股东变化：截至4月10日股东户数降至6.1万户，户均持股升至1.47万股，筹码略有集中。股本股东变化股东户数变动近日欧普康视披露，截至2026年4月10日公司股东户数为6.1万户，较3月31日减少94.0户，减幅为0.15%。户均持股数量由上期的1.46万股增加至1.47万股，户均持股市值为20.85万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042000001023.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628917209","title":"欧普康视：公司尚无在研智能隐形眼镜项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2628917209","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628917209?lang=zh_cn&edition=full","pubTime":"2026-04-17 20:52","pubTimestamp":1776430332,"startTime":"0","endTime":"0","summary":"证券之星消息，欧普康视04月16日在投资者关系平台上答复投资者关心的问题。硬镜材料能否使用在ai隐形眼镜？欧普康视回复：您好，公司在角膜塑形镜设计和验配中使用了一些算法，具有智能化特征，但没有使用大模型；多焦软镜在注册审评中；公司目前没有立项眼压监测这类传感隐形眼镜；公司目前持有博视医疗3.6585%的股份；公司尚无在研智能隐形眼镜项目。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041700043138.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628485782","title":"股市必读：欧普康视（300595）4月16日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2628485782","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628485782?lang=zh_cn&edition=full","pubTime":"2026-04-17 01:44","pubTimestamp":1776361451,"startTime":"0","endTime":"0","summary":"截至2026年4月16日收盘，欧普康视报收于14.21元，上涨0.07%，换手率1.05%，成交量6.99万手，成交额9902.16万元。当日关注点来自交易信息汇总：4月16日主力资金净流出1486.18万元，散户资金净流入1033.7万元。硬性接触镜收入下滑主要原因为高端消费疲软、竞争品牌增多导致市场加剧、功能性框架镜等其他近视防控产品抢占市场份额。公司持续依照国家标准和质量管理体系开展产品质量管控、验配流程规范及不良反应上报等工作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041700002908.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300595","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627103027","title":"股市必读：欧普康视（300595）4月10日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2627103027","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627103027?lang=zh_cn&edition=full","pubTime":"2026-04-13 01:15","pubTimestamp":1776014112,"startTime":"0","endTime":"0","summary":"截至2026年4月10日收盘，欧普康视报收于14.22元，上涨1.28%，换手率0.91%，成交量6.11万手，成交额8708.79万元。董秘最新回复投资者： 咱们公司的复合控功能框架眼镜，是否有产品迭代更新的计划？","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041300000584.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626190782","title":"欧普康视：复合控的功能体现在镜片的设计上","url":"https://stock-news.laohu8.com/highlight/detail?id=2626190782","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626190782?lang=zh_cn&edition=full","pubTime":"2026-04-10 20:48","pubTimestamp":1775825296,"startTime":"0","endTime":"0","summary":"证券之星消息，欧普康视(300595)04月10日在投资者关系平台上答复投资者关心的问题。投资者提问：咱们公司的复合控功能框架眼镜，是否有产品迭代更新的计划？有没有计划增加ai功能？欧普康视回复：您好，复合控的功能体现在镜片的设计上，采用了减少周边远视离焦和调节对比度的特殊光学设计并使用光刻技术实现，达到减缓近视发展的作用。目前没有配备具有智能化功能的镜架。如市场有需求，可以配备具有相关功能的镜架。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041000038813.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300595","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626164765","title":"欧普康视：公司成本和收入和国际油价没有直接相关性","url":"https://stock-news.laohu8.com/highlight/detail?id=2626164765","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626164765?lang=zh_cn&edition=full","pubTime":"2026-04-10 15:03","pubTimestamp":1775804589,"startTime":"0","endTime":"0","summary":"证券之星消息，欧普康视(300595)04月10日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司成本或收入和国际原油价格有相关性吗？还是说大股东或公司参与了国际商品炒作？欧普康视回复：您好，公司成本和收入和国际油价没有直接相关性。公司从未参与国际商品炒作。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041000020092.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626697764","title":"欧普康视：全视光产品矩阵、全年龄段视光服务","url":"https://stock-news.laohu8.com/highlight/detail?id=2626697764","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626697764?lang=zh_cn&edition=full","pubTime":"2026-04-09 11:30","pubTimestamp":1775705444,"startTime":"0","endTime":"0","summary":"证券之星消息，欧普康视(300595)04月09日在投资者关系平台上答复投资者关心的问题。投资者提问：您好，多年来持有贵公司股票，已是损失惨重，请问如何提升投资者对欧普的信心？如何提升对陶董的信任呢？欧普康视回复：您好，公司一直在按照“全视光产品矩阵、全年龄段视光服务”的战略推进各项工作，包括组织架构和人员的优化调整，已推出了多个新产品和新的视光服务项目，同步在进行降本增效的管理优化，各项工作及进展均会在定期报告和投资者交流会中披露。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040900015117.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625053786","title":"股市必读：欧普康视(300595)股东户数6.11万户，较上期减少0.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625053786","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625053786?lang=zh_cn&edition=full","pubTime":"2026-04-07 02:19","pubTimestamp":1775499550,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，欧普康视报收于13.78元，下跌2.82%，换手率1.24%，成交量8.26万手，成交额1.15亿元。交易信息汇总资金流向4月3日主力资金净流出1078.84万元，占总成交额9.38%；游资资金净流入282.11万元，占总成交额2.45%；散户资金净流入796.74万元，占总成交额6.93%。股本股东变化股东户数变动近日欧普康视披露，截至2026年3月31日公司股东户数为6.11万户，较3月20日减少472.0户，减幅为0.77%。户均持股数量由上期的1.45万股增加至1.46万股，户均持股市值为20.69万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700000927.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300595","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625641351","title":"东吴证券：给予欧普康视增持评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2625641351","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625641351?lang=zh_cn&edition=full","pubTime":"2026-04-05 18:45","pubTimestamp":1775385920,"startTime":"0","endTime":"0","summary":"东吴证券股份有限公司朱国广近期对欧普康视进行研究并发布了研究报告《2025年业绩承压，期待逐步恢复》，给予欧普康视增持评级。　　盈利预测与投资评级：考虑到国内高端消费有待恢复，我们将公司2026-2027年归母净利润从6.81/7.30亿元下调至5.57/6.08亿元，预计2028年归母净利润为6.60亿，对应当前市值的PE分别为22/20/19倍，考虑到公司产品线不断丰富，有望恢复稳健增长态势，维持“增持”评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040500009021.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601555","300595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624510306","title":"欧普康视利润连续两年下滑、市值蒸发近800亿 核心产品硬性接触镜销售承压、商誉激增近六成藏隐患","url":"https://stock-news.laohu8.com/highlight/detail?id=2624510306","media":"新浪证券","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624510306?lang=zh_cn&edition=full","pubTime":"2026-04-03 18:30","pubTimestamp":1775212200,"startTime":"0","endTime":"0","summary":"　　昔日被誉为“OK镜一哥”的欧普康视，正经历上市以来最严峻的业绩考验。这家国内角膜塑形镜领域的龙头企业，在2025年交出了一份“增收不增利”的成绩单——营收虽创下历史新高，净利润却连续第二年出现两位数下滑，核心产品硬性接触镜收入更是陷入连年萎缩的困境。　　“硬镜龙头”欧普康视的困境：市值蒸发近800亿，核心产品收入连降两年，2025年净利再跌16.2%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/observe/2026-04-03/doc-inhtfkwz8839288.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0251","300595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624582296","title":"欧普康视：截止到2026年3月31日，公司股东总人数为61,141户","url":"https://stock-news.laohu8.com/highlight/detail?id=2624582296","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624582296?lang=zh_cn&edition=full","pubTime":"2026-04-03 15:18","pubTimestamp":1775200704,"startTime":"0","endTime":"0","summary":"证券之星消息，欧普康视(300595)04月02日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问截止到2026年3月31日公司股东人数是多少？谢谢！欧普康视回复：您好，截止到2026年3月31日，公司股东总人数为61,141户。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300023977.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624560593","title":"欧普康视：目前角膜塑形镜的适配人群的最低近视度数为50度","url":"https://stock-news.laohu8.com/highlight/detail?id=2624560593","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624560593?lang=zh_cn&edition=full","pubTime":"2026-04-01 15:04","pubTimestamp":1775027058,"startTime":"0","endTime":"0","summary":"证券之星消息，欧普康视(300595)03月31日在投资者关系平台上答复投资者关心的问题。投资者提问：你好，孩子还小远视储备不多了，可以预防性佩戴吗欧普康视回复：您好，目前角膜塑形镜的适配人群的最低近视度数为50度。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040100021999.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300595","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624560890","title":"欧普康视：公司2025年新增的商誉主要来自对宿迁尚悦启程的收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2624560890","media":"证券之星","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624560890?lang=zh_cn&edition=full","pubTime":"2026-04-01 15:00","pubTimestamp":1775026844,"startTime":"0","endTime":"0","summary":"证券之星消息，欧普康视(300595)03月31日在投资者关系平台上答复投资者关心的问题。投资者提问：2025年，公司商誉达到总资产的14.12%，但商誉减值准备为0.88%，请问公司是否利用商誉减值操纵利润？欧普康视回复：您好，溢价收购就会产生商誉，商誉值就是收购价和净资产的差额，没有人为改变的空间，公司2025年新增的商誉主要来自对宿迁尚悦启程的收购。至于商誉减值，按照会计准则每年度末要对商誉进行减值测试，并经审计复核确认，不存在调节利润的情形。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040100021944.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300595","BK0251"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1777541886961,"stockEarnings":[{"period":"1week","weight":0.0049},{"period":"1month","weight":0.0056},{"period":"3month","weight":-0.103},{"period":"6month","weight":-0.1394},{"period":"1year","weight":-0.0019},{"period":"ytd","weight":-0.0272}],"compareEarnings":[{"period":"1week","weight":0.0003},{"period":"1month","weight":0.047},{"period":"3month","weight":-0.0121},{"period":"6month","weight":0.0386},{"period":"1year","weight":0.2498},{"period":"ytd","weight":0.0349}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"欧普康视科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"61017人(较上一季度减少0.05%)","perCapita":"10955股","listingDate":"2017-01-17","address":"安徽省合肥市蜀山区高新区望江西路4899号","registeredCapital":"89528万元","survey":"　　欧普康视科技股份有限公司的主营业务是专注眼视光产品及相关配套产品的研发、生产、销售，以及眼视光服务。公司的主要产品是硬性接触镜类及其护理产品、硬镜以外的其它视光产品、其它眼健康产品。公司是目前国内及全球领先的角膜塑形镜研发与生产企业。","listedPrice":23.81},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"欧普康视(300595)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供欧普康视(300595)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"欧普康视,300595,欧普康视股票,欧普康视股票老虎,欧普康视股票老虎国际,欧普康视行情,欧普康视股票行情,欧普康视股价,欧普康视股市,欧普康视股票价格,欧普康视股票交易,欧普康视股票购买,欧普康视股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"欧普康视(300595)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供欧普康视(300595)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}